Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. 2002

Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
Fox Chase Cancer Center, 7701 Burholme Avenue, Philadelphia, Pennsylvania, PA 19111, USA.

Tuberous sclerosis complex (TSC) is a tumor suppressor gene syndrome characterized by seizures, mental retardation, autism, and tumors of the brain, kidney, heart, retina, and skin. TSC is caused by mutations in either TSC1 or TSC2, both of which are tumor suppressor genes. Hamartin, the protein product of TSC1, was found to interact with the ezrin-radixin-moesin family of cytoskeletal proteins and to activate the small GTPase Rho. To determine whether tuberin, the TSC2 product, can also activate Rho, we stably expressed full-length human tuberin in two cell types: MDCK cells and ELT3 cells. ELT3 cells lack endogenous tuberin expression. We found that expression of human tuberin in both MDCK and ELT3 cells was associated with an increase in the amount of Rho-GTP, but not in Rac1-GTP or cdc42-GTP. Tuberin expression increased cell adhesion in both cell types, and decreased chemotactic cell migration in ELT3 cells. In MDCK cells, there was a decrease in the amount of total Focal Adhesion Kinase (FAK) and an increase in the fraction of phosphorylated FAK. These findings demonstrate for the first time that tuberin activates Rho and regulates cell adhesion and migration. Pathways involving Rho activation may have relevance to the clinical manifestations of TSC, including pulmonary lymphangioleiomyomatosis.

UI MeSH Term Description Entries
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002448 Cell Adhesion Adherence of cells to surfaces or to other cells. Adhesion, Cell,Adhesions, Cell,Cell Adhesions
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002465 Cell Movement The movement of cells from one location to another. Distinguish from CYTOKINESIS which is the process of dividing the CYTOPLASM of a cell. Cell Migration,Locomotion, Cell,Migration, Cell,Motility, Cell,Movement, Cell,Cell Locomotion,Cell Motility,Cell Movements,Movements, Cell
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077004 Tuberous Sclerosis Complex 1 Protein An intracellular signaling and tumor suppressor protein that forms a complex with TUBEROUS SCLEROSIS COMPLEX 2 PROTEIN (TSC2) and other signaling factors to negatively regulate MTORC1 signaling and affect cell growth and proliferation. Structurally, it interacts with TSC2 through its N-terminal, which also contains GSK-3BETA phosphorylation sites and a RHO-KINASE activation domain. It also contains a C-terminal coiled-coil domain and ezrin-radixin-moesin (ERM) domain. Mutations in the TSC1 gene are associated with TUBEROUS SCLEROSIS. Hamartin
D000077005 Tuberous Sclerosis Complex 2 Protein An intracellular signaling and tumor suppressor protein that forms a complex with TUBEROUS SCLEROSIS COMPLEX 1 PROTEIN (TSC1) and other signaling factors to negatively regulate MTORC1 and affect cell growth and proliferation. It can also function as GTPASE-ACTIVATING PROTEIN (GAP) for RHEB GTPASE to activate mTORC1 independent of its role in the complex. Structurally, it interacts with TSC1 through its N-terminus, which also contains a leucine zipper and coiled-coil region. It also has multiple phosphorylation sites for different cell signaling kinases, a central coiled-coil region, a C-terminal GAP domain and CALMODULIN binding domain. Mutations in the TSC2 gene are associated with TUBEROUS SCLEROSIS. Tuberin,Tuberous Sclerosis 2 Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
January 2003, The Journal of biological chemistry,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
July 2002, Molecular cell,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
October 2016, The Journal of biological chemistry,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
September 2002, The Journal of biological chemistry,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
October 2001, Journal of cutaneous pathology,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
May 2002, Journal of cutaneous pathology,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
September 2005, Surgery,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
July 1995, The Journal of biological chemistry,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
August 2010, The Journal of biological chemistry,
Aristotelis Astrinidis, and Timothy P Cash, and Deborah S Hunter, and Cheryl L Walker, and Jonathan Chernoff, and Elizabeth P Henske
April 1996, Neurobiology of disease,
Copied contents to your clipboard!